CarolineG.WilkerMD

PubMed

• 2 citations
  Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening S...
  Patrick W Johnson, Katie L Kunze, Jonathon W Senefeld, Jorge E Sinclair, Shahin Isha, Parthkumar H Satashia, Shivang Bhakta, Jennifer B Cowart, Wendelyn Bosch, Jack O'...> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2023 Apr 1
• 15 citations
  Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant.
  John C O'Horo, Douglas W Challener, Leigh Speicher, Wendelyn Bosch, Maria Teresa Seville, Dennis M Bierle, Ravindra Ganesh, Caroline G Wilker, Richard F Arndt, Lori L ...> ;Mayo Clinic Proceedings. 2022 Feb 1
• 37 citations
  Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
  Dennis M. Bierle, Ravindra Ganesh, Sidna M. Tulledge-Scheitel, Sara N. Hanson, Lori L Arndt, Caroline G. Wilker, Raymund R. Razonable> ;The Journal of Infectious Diseases. 2021 Nov 16
• 2 citations
  Computer-Based Patient Bias and Misconduct Training Impact on Reports to Incident Learning System.
  Caroline G. Wilker, Abigail L. Stockham, Benjamin J. Houge, Sheila K. Stevens, Karee A. Munson, Paul S. Mueller> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2021 Nov 14
• 63 citations
  Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019.
  Ravindra Ganesh, Lindsey M. Philpot, Dennis M. Bierle, Ryan J. Anderson, Lori L Arndt, Richard F. Arndt, Tracy L. Culbertson, Molly J. Destro Borgen, Sara N. Hanson, B...> ;The Journal of Infectious Diseases. 2021 Oct 28
• 26 citations
  Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.
  Ravindra Ganesh, Colin Pawlowski, John C. O’Horo, Lori L Arndt, Richard F. Arndt, Sarah J. Bell, Dennis M. Bierle, Molly J. Destro Borgen, Sara N. Hanson, Alexander He...> ;The Journal of Clinical Investigation. 2021 Oct 1
• 83 citations
  Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
  Raymund R. Razonable, Colin Pawlowski, John C. O’Horo, Lori L Arndt, Richard F. Arndt, Dennis M. Bierle, Molly J. Destro Borgen, Sara N. Hanson, Michelle C. Hedin, Pat...> ;Eclinicalmedicine. 2021 Aug 30
• 5 citations
  Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
  Ravindra Ganesh, Colin Pawlowski, John C. O’Horo, Lori L Arndt, Richard F. Arndt, Sarah J. Bell, Dennis M. Bierle, Molly J. Destro Borgen, Sara N. Hanson, Alexander He...> ;Medrxiv. 2021 May 25
• 39 citations
  A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model.
  Raymund R. Razonable, Nicole C.E. Aloia, Ryan J. Anderson, Gokhan Anil, Lori L Arndt, Richard F. Arndt, Sara Ausman, Sarah J. Bell, Dennis M. Bierle, Marcie Billings, ...> ;Mayo Clinic Proceedings. 2021 May 1
• 36 citations
  Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19.
  Dennis M. Bierle, Ravindra Ganesh, Caroline G. Wilker, Sara N. Hanson, Darcie E. Moehnke, Tammy A. Jackson, Priya Ramar, Jordan K. Rosedahl, Lindsey M. Philpot, Raymun...> ;Journal of Primary Care & Community Health. 2021 Jan 1
• Join now to see all